DR. K. DEMUYNCK

Active

Private limited companyfounded 2007active for 19 yearsMerellaan 46, 3570 Alken, BelgiumKBO/BCE: BE 0886.104.502

From the official registers: KBO 19 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. K. DEMUYNCK has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €437,927. Equity has been growing by about 13% per year since 2018. The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

DR. K. DEMUYNCKActiveChecked score 95/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 02-01-2007 Normal situation
Legal form: Private limited company
Registered office: Merellaan 46, 3570 Alken
Activity: “Het uitoefenen van de geneeskunde door geneesheren-vennoten.” (deed in Dutch)From the articles, 4 activitiesNo NACE code in the KBO yet
Financial year end: 31 December
Peppol: Reachable since 23-01-2025

Company details

Board and ownership

Board

Demuynck KoenraadDirector

Board & ownership

Financial position

95 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €542,516; ▼ 11.4%
Turnover: ≈ €1.1m; estimated
Profit: €437,927; ▲ 4.1%
Equity: €1.9m; ▼ 21.0%
Total assets: €2.3m; ▼ 5.1%

2025 accounts filed 32 days before the deadline

Filed on 29-06-2026at the National Bank

Financials

Score breakdownraises riskNo registered site in the KBOlowers riskSize: total assets €2.3mFigures for financial year 2025 (filed on 29-06-2026)Equity €1.9m (80.9% of total assets)Show the evidence

Checked score

Score 2025

95 / 100

Excellent

Probability in this band: under 0.55%

Financially stronger than 57% of small companies without a NACE code

Every signal that counts is listed under Signals.

Financial strength · tick: 2024

Strong

Solvency 100=

equity 80.9% of total assets

Liquidity 49-7

short-term debt 18.8% · cash 3.5%

Profitability 93+3

return on assets 19.0%

Bankruptcy probability within 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.2 percentage points vs 05-2025 07-2025: 0.5%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.2%▼ -0.3 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: < 0.1%▼ -0.2 percentage points vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: < 0.1%▼ -0.2 percentage points vs 09-2026

Credit of up to €170,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 5.15 (34.31 in 2024), above the usual 1.5. Short-term debt is 18.8% and cash 3.5% of total assets. 19.1% of the assets are financed with debt and provisions.

Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, small). It does better than 82% of them on solvency, 39% on liquidity, 95% on profitability and 12% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Size: total assets €2.3m

Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.

NBB · annual accounts

Figures for financial year 2025 (filed on 29-06-2026)

NBB · annual accounts

No registered site in the KBO

KBO · seat and establishments

Equity €1.9m (80.9% of total assets)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

32 days early

2024

31 days early

2023

7 days early

2022

7 days early

2021

4 days early

2020

9 days early

2019

on the day

← before the deadline after the deadline →

tick = median of all Belgian filings

The company filed its last 7 accounts on average 13 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 July (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Key points

Positive: 8 profitable years in a rowprofit 2025: €437,927 8 years View
Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

Documents

Key facts about DR. K. DEMUYNCK

What is the company number of DR. K. DEMUYNCK?: The company number of DR. K. DEMUYNCK is 0886.104.502. The VAT number is the same number with BE in front: BE 0886.104.502.
Where is DR. K. DEMUYNCK based?: The registered office is at Merellaan 46, 3570 Alken.Company details
What is the legal form of DR. K. DEMUYNCK?: The legal form of DR. K. DEMUYNCK is Private limited company (BV).
When was DR. K. DEMUYNCK founded?: DR. K. DEMUYNCK was founded on 02-01-2007.
Is DR. K. DEMUYNCK still active?: Yes, DR. K. DEMUYNCK is an active enterprise in the KBO register.
What is the turnover of DR. K. DEMUYNCK?: The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €542,516 and 881 comparable companies of the same size. It probably lies between €760,000 and €1.6m. It is a rough estimate.Financials
Is DR. K. DEMUYNCK profitable?: In financial year 2025, DR. K. DEMUYNCK made a profit of €437,927.
Where can I find the annual accounts of DR. K. DEMUYNCK?: DR. K. DEMUYNCK filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. K. DEMUYNCK due?: DR. K. DEMUYNCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline